Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Helen Torley currently holds 44,872 shares of HALOZYME THERAPEUTICS INC (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Helen Torley has been a net seller of HALO stock. They have purchased $446.0K and sold $66.5M worth of shares.
Helen Torley's most recent insider trade was on Feb 23, 2026, when they sold 22,436 shares at $0.00 per share.
Helen Torley serves as Executive at HALOZYME THERAPEUTICS INC (HALO). They have executed 304 insider transactions totaling $67.0M over their tenure at the company.
Helen Torley holds the position of Executive at HALOZYME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Helen Torley has shown a selling trading pattern, with $446.0K in total purchases and $66.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Helen Torley was on Nov 10, 2025, when they sold $1.4M worth of HALO shares. This transaction involved 19,900 shares at $68.71 per share.
Helen Torley currently owns 44,872 shares of HALOZYME THERAPEUTICS INC (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Helen Torley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Helen Torley has 304 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS INC.
Set alerts for Helen Torley and 40,000+ other insiders.